These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22553078)

  • 1. Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.
    Zwanzger P; Domschke K; Bradwejn J
    Depress Anxiety; 2012 Sep; 29(9):762-74. PubMed ID: 22553078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene variations in the cholecystokinin system in patients with panic disorder.
    Koefoed P; Woldbye DP; Hansen TO; Hansen ES; Knudsen GM; Bolwig TG; Rehfeld JF
    Psychiatr Genet; 2010 Apr; 20(2):59-64. PubMed ID: 20023595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin and panic disorder--three unsettled questions.
    Rehfeld JF
    Regul Pept; 2000 Sep; 93(1-3):79-83. PubMed ID: 11033055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7.
    Binkley K; King N; Poonai N; Seeman P; Ulpian C; Kennedy J
    J Allergy Clin Immunol; 2001 May; 107(5):887-90. PubMed ID: 11344357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the 'central' cholecystokinin-B receptor in panic disorder.
    Megen HJ; Westenberg HG; Boer JA
    Acta Neuropsychiatr; 1996 Dec; 8(4):99-101. PubMed ID: 26964658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies.
    Harro J
    Amino Acids; 2006 Oct; 31(3):215-30. PubMed ID: 16738800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cAMP-dependent gene expression by cholecystokinin in the hippocampus.
    Nakamura NH; Akiyama K; Naito T
    Neuroscience; 2011 Jul; 187():15-23. PubMed ID: 21540082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiology of cholecystokinin.
    Moran TH; Schwartz GJ
    Crit Rev Neurobiol; 1994; 9(1):1-28. PubMed ID: 8828002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of cholecystokinin system genes in panic disorder.
    Kennedy JL; Bradwejn J; Koszycki D; King N; Crowe R; Vincent J; Fourie O
    Mol Psychiatry; 1999 May; 4(3):284-5. PubMed ID: 10395221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is cholecystokinin a biological support in panic attacks?].
    Bourin M; Bradwejn J; Koszycki D
    Encephale; 1991; 17(5):475-9. PubMed ID: 1686250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
    Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
    Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
    Goldman JG; Goetz CG; Berry-Kravis E; Leurgans S; Zhou L
    Arch Neurol; 2004 Aug; 61(8):1280-4. PubMed ID: 15313848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
    Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
    Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropharmacological and genetic study of panic disorder].
    Akiyoshi J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Jul; 19(3):93-9. PubMed ID: 10495983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From inducers of panic attack to neurobiology of panic disorder].
    Bourin M
    Encephale; 1996 Dec; 22 Spec No 5():35-41. PubMed ID: 9138945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
    Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
    Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin and Panic Disorder: Reflections on the History and Some Unsolved Questions.
    Rehfeld JF
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E; Tõru I; Tasa G; Must A; Toover E; Lang A; Vasar V; Shlik J
    Neurosci Lett; 2008 Dec; 446(2-3):88-92. PubMed ID: 18832011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.